Celaid Therapeutics Completes Second Close of Series B Financing Round
Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 5, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO:...
Dioseve Secures JPY 1.45 Billion to Advance iPS Cell‑Based IVF Support, Adds TIME100 Scientist as Advisor
Funding round and NEDO Deep Tech Startup Support Program selection will support development and clinical adoption of DIOS ‑ 101, an iPS cell ‑ derived co ‑ culture designed to reduce the burden of IVF treatment. TOKYO, June 17, 2026 /PRNewswire/ --...